A new radiotracer can identify nearly 30 types of cancer, according to research featured in the June issue of The Journal of Nuclear Medicine. The tracer has potential for treating cancer in the future. #Cancer #PrecisionMedicine #NuclearMedicine ow.ly/LPh830oU71t
SNMMI
6,160 posts
An international scientific and medical organization dedicated to raising public awareness about molecular imaging. Visit us at snmmi.org
- SNMMI 2023 Image of the Year: New theranostic pair facilitates early detection and effective treatment of #PancreaticCancer. Congratulations to Julie Sutcliffe, PhD, and colleagues! ow.ly/CExu50OWB1T #SNMMI23 #MedicalResearch
- Big news: Today the FDA approved 18F-DCFPyL, a new imaging agent for diagnosis of prostate cancer, providing a more effective imaging approach for detecting metastasis or recurrence. ow.ly/6ROv30rJ4GM #ProstateCancer #MedicalImaging #PETimaging #PSMA
- Molecular imaging pioneer Sanjiv “Sam” Gambhir, MD, PhD, passed away on Saturday, July 18. He was a brilliant researcher and a wonderful human being. ow.ly/jFq250AClBH #NuclearMedicine
- Peter J. H. Scott, PhD, has been named as the 2023 recipient of the SNMMI Sam Gambhir Trailblazer Award. Congratulations on this honor! ow.ly/aPEj50OWB3f #SNMMI23 #NuclearMedicine
- SNMMI 2022 Image of the Year: Predicting Remodeling and Outcome from Molecular Imaging of Fibroblast Activation in Patients after Acute Myocardial Infarction. Congratulations! ow.ly/tiwS50JxHfk #SNMMI22 #PETimaging #MedicalResearch
- SNMMI 2021 Image of the Year: PET Imaging Measures Cognitive Impairment in COVID-19 Patients. Congratulations! #SNMMI21 #COVID19 #PETimaging #MedicalResearch
- Andrei Iagaru, MD, FACNM, has been named as the first recipient of the SNMMI Sam Gambhir Trailblazer Award. Congratulations on this honor! #SNMMI22 #NuclearMedicine
- #SNMMI18 - SNMMI Image of the Year: PSMA PET Imaging of Theranostic for Advanced Prostate Cancer. #ProstateCancer #theranostic snmmi.org/NewsPublicatio…
GIF - SNMMI’s Image of the Year award goes to an image showcasing the efficacy of the FAPI radiotracer, which allows for new applications in noninvasive diagnosis, staging and treatment. #cancer #MedicalResearch #NuclearMedicine #SNMMI19 ow.ly/eeTX30p0wmp
- Congratulations are in order for Henry VanBrocklin, PhD, FSNMMI, FSRS, the 2023 recipient of the prestigious SNMMI Paul C. Aebersold Award for outstanding achievement in basic nuclear medicine science. ow.ly/sF3l50OWAT6 #SNMMI23 #NuclearMedicine
- SNMMI applauds today’s FDA approval of a new, game-changing #NuclearMedicine treatment for metastatic #ProstateCancer shown to reduce risk of death by 38% and risk of progression by 60% in #mCRPC patients. ow.ly/fYiy30sfgPU #PrecisionMedicine #RadiopharmaceuticalTherapy
- The FDA has approved a new process for producing Ga-68 DOTATOC, which localizes neuroendocrine tumors in adult and pediatric patients. The process uses cyclotron-produced Ga-68, which will allow for higher-volume production. ow.ly/h8JP30rfZaX #NuclearMedicine #NETCancer
- Ultra-low dose total-body PET/CT effective for evaluating #arthritis, according to new research from @JournalofNucMed. ow.ly/RZ2850L99JR #MedicalImaging #PETCT #JNuclMed














